Finally, FVB/NJ mice were inoculated with cells from their prostate cancer model (PtenPC−/−Smad4PC−/−) and treated with a small-molecule inhibitor of RNF2, identified in a screen of a compound library–inhibited metastasis. Here, RNF2 is linked to prostate carcinoma.